All In MedTech

Device Trial Radar · NCT07482696

Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation

Effects of Game-Based Electromyographic Biofeedback Therapy on Quality of Life and Sleep Quality in Patients With Dyssynergic Defecation

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Mar 31, 2026

Primary completion

Oct 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Kocaeli UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 19, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aimed to investigate the effects of game-based electromyographic (EMG) biofeedback therapy on the quality of life and sleep quality of individuals diagnosed with dyssynergic defecation.

Conditions

  • Defecation Disorder

Interventions

  • Game-Based Electromyographic (EMG) Biofeedback TherapyDevice

    Game-based biofeedback integrates real-time visual feedback with interactive tasks, allowing patients to actively control on-screen elements through appropriate muscle activation and relaxation. This approach supports motor learning principles, promotes neuromuscular adaptation, and may improve treatment compliance.

  • Sham ControlDevice

    Sham EMG biofeedback therapy will be administered alongside the same standard pelvic floor rehabilitation program with identical session frequency and duration. Surface electrodes will be placed in the same anatomical locations; however, the biofeedback device will operate in demo mode, and visual feedback will not reflect actual muscle activity.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient Assessment of Constipation-Quality of Life QuestionnaireTime frame: At baseline, immediately after the intervention, and 2-months after the intervention.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kocaeli University

    Kocaeli, Izmit, Turkey (Türkiye) · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.